← Evidence map

ReviewMolecular oncology2022

MYC and therapy resistance in cancer: risks and opportunities.

Giulio Donati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

72 papers cite itlatest 60 shown

2022
…
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36214609